ANDREW NIK: Open Payments
NPI 1316177520 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 105 payments from 27 companies in 2025. Trend: 2023 $1,964 · 2024 $2,769 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $708 |
| Biogen, Inc. | 12 | $194 |
| PFIZER INC. | 10 | $173 |
| ACADIA Pharmaceuticals Inc | 4 | $126 |
| SK Life Science, Inc. | 4 | $102 |
| Amgen Inc. | 3 | $78 |
| ARGENX US, INC. | 2 | $68 |
| MDD US Operations, LLC | 2 | $63 |
| Alexion Pharmaceuticals, Inc. | 2 | $54 |
| UCB, Inc. | 1 | $49 |
Products named: QULIPTA, BOTOX, UBRELVY, LEQEMBI, NURTEC ODT, NUPLAZID, UPLIZNA, VYALEV.
Industry payments across CA — which companies pay providers there.
